The African Centre for Biodiversity (ACB) welcomes you to our website. We are a research and advocacy organisation working towards food sovereignty and agro-ecology in Africa, with a focus on biosafety, seed systems and agricultural biodiversity. The organisation is committed to dismantling inequalities and resisting corporate-industrial expansion in Africa's food and agriculture systems.

Collage drawing of women farmers preparing food and sowing as well as a field and different vegetables.

Civil society statement on the Supplementary Budget and the implications for food security and land reform

Civil Society Statement

Context: engulfed by multiple crises

The Minister of Finance has announced an austerity budget at a time when the fissures of unresolved historical inequality, poverty and suffering are made so much sharper. The lives of people are going to be made so much worse, at a time when redistributive and social measures are needed most. It is shocking that these measures are not the focus of the budget, despite the fact that the pandemic has exposed the vulnerabilities and inequalities in the society, and will deepen these issues with income loss, prolonged hunger and other negative health and social impacts. Instead the government is aiming to go from deep debt to a budget surplus in as little as four years, which is short-sighted and unlikely and will rather reinforce and perpetuate societal ills.

ACB raises concerns on GM Covid-19 vaccine trials for SA, calls for transparency & public hearings

Civil Society Statement

Clique aqui para a versão portuguesa

Por favor, haga clic aquí para el español

The African Centre for Biodiversity (ACB) has made a submission to the Registrar of GMOs in South Africa, following an application made by Professor Shabir Ahmed Madhi, from the Respiratory and Meningeal Pathogens Research Unit (RMPRU), Chris Hani Baragwanath Academic Hospital, for approval for release of ChAdOx1 nCo-V-19, a genetically modified (GM) vaccine, for clinical phase I/II trials on 2 800 both healthy and HIV-positive adults over a period of 12 months.